$1M NIGMS grant gives students at Lewis Katz School of Medicine chance at early success
(Temple University Health System) A new $1 million T32 predoctoral training grant from the National Institute of General Medical Sciences (NIGMS) within the National Institutes of Health (NIH) will provide two years of support for training, research, and travel to conferences for a total of 15 PhD and MD/PhD students in the Biomedical Sciences Graduate Program at the Lewis Katz School of Medicine at Temple University over a five-year period. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
Addressing social needs may help mitigate distress and improve the health of women with cancer
(Wiley) A new study published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society, has identified unmet social needs in women with gynecologic cancer that could be addressed to improve care for patients and lessen disparities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia
(Impact Journals LLC) These Oncotarget findings demonstrate that Tomivosertib exhibits potent anti-leukemic properties on AML cells and support the development of clinical translational efforts involving the use of this drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network
(Impact Journals LLC) EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: LAPAS1 is required for S phase progression and cell proliferation
(Impact Journals LLC) They identify LAPAS1 as a novel E2F-regulated lncRNA that has a potential role in human cancer and regulates cell-cycle progression and cell proliferation (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
MD Anderson and Hummingbird Bioscience announce strategic research collaboration to advance innovative immunotherapies
(University of Texas M. D. Anderson Cancer Center) MD Anderson and Hummingbird Bioscience announced a multi-year strategic research collaboration to investigate HMBD-002, Hummingbird's VISTA antagonist antibody, as a novel immunotherapy for cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 12, 2021 Category: Cancer & Oncology Source Type: news
Standigm secures $10 million From Pavilion Capital to accelerate its global competitiveness
(Standigm Inc.) " I thank Pavilion Capital for their support to further strengthen Standigm's specialized workflow AI technology in developing first-in-class drug compounds, " said Jinhan Kim, co-founder and CEO of Standigm. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 11, 2021 Category: Cancer & Oncology Source Type: news
Obesity increases survival in advanced prostate cancer
(European Association of Urology) Obese patients with a form of advanced prostate cancer survive longer than overweight and normal weight patients, new research has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2021 Category: Cancer & Oncology Source Type: news
Beautiful VR setting could reduce pain in unpleasant medical procedure
(European Association of Urology) Being immersed in a stunning 'virtual' Icelandic landscape can reduce the pain caused by uncomfortable medical procedures, new research has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2021 Category: Cancer & Oncology Source Type: news
New concept drug hunts down late-stage prostate cancer
(European Association of Urology) A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumour cells, is well tolerated by patients and keeps them alive for longer than standard care, found a phase 3 trial to be presented at the European Association of Urology congress, EAU21, today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2021 Category: Cancer & Oncology Source Type: news
New use of old drug reduces risk of kidney cancer returning
(European Association of Urology) Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2021 Category: Cancer & Oncology Source Type: news
MRI can cut overdiagnoses in prostate-cancer screening by half
(Karolinska Institutet) Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half. The results are presented today at the European Association of Urology Congress. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2021 Category: Cancer & Oncology Source Type: news
Oncotarget: Urine RNA reveal tumor markers for human bladder cancer
(Impact Journals LLC) This Oncotarget work strongly suggests exploiting urine RNAs as diagnostic markers of bladder cancer and it suggests specific novel markers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2021 Category: Cancer & Oncology Source Type: news
Nicotine by-product can predict recurrence of cancer
(European Association of Urology) A by-product of nicotine, found in the urine of smokers, could be used to identify when bladder cancer has returned, new research has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2021 Category: Cancer & Oncology Source Type: news
Pfizer-BioNTech vaccine in patients undergoing cancer treatment
(JAMA Network)What The Study Did:The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccineappeared to be safe and achieve satisfactory serologic status in patients with cancer. While therewas a lag in antibody production compared with the rate in the noncancer control group,seroconversion occurred in most patients after the second dose. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2021 Category: Cancer & Oncology Source Type: news
